Follow on Google News News By Tag * Therapeutics * Gbs * Syndrome * Guillain * Barre * 2010-2017 * Pipeline * Globaldata * Implications * Csl * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Now Available: "Guillain Barre Syndrome (GBS) Therapeutics Market Forecasts to 2017"New Pharmaceuticals research report from GlobalData is now available from Fast Market Research
Summary GlobalData, the industry analysis specialist, has released its new report, "Guillain Barre Syndrome (GBS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Guillain Barre Syndrome market. The report identifies the key trends shaping and driving the global Guillain Barre Syndrome market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Guillain Barre Syndrome sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and inhouse analysis by GlobalData's team of industry experts. GlobalData's analysis revealed that the global Guillain Barre Syndrome market was worth $370m in 2010. It is forecast to grow at a compound annual growth rate (CAGR) of 5.1% over the next seven years, to reach $520m by 2017. This is primarily attributed to the predicted increase in the prevalence of the disease. ------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ Scope The report provides information on the key drivers and challenges of the Guillain Barre Syndrome market.Its scope includes - * Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Guillain Barre Syndrome market revenues data from 2005 to 2010, forecast for seven years to 2017. * Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. * Analysis of the current and future competition in the seven key countries Guillain Barre Syndrome market. Key market players covered are Baxter Biotherapeutics, Grifols Biologics Inc. and CSL Behring. * Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. * Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Guillain Barre Syndrome therapeutics market. * Analysis of key recent licensing and partnership agreements in Guillain Barre Syndrome market. Reasons to buy The report will enhance your decision making capability. It will allow you to - * Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. * Develop business strategies by understanding the trends shaping and driving the global Guillain Barre Syndrome market. * Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Guillain Barre Syndrome market in future. * Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. * Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage. * Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. * What's the next big thing in the global Guillain Barre Syndrome market landscape? - Identify, understand and capitalize. Partial Table of Contents: 1 Table of contents 1 Table of contents 1.1 List of Tables 1.2 List of Figures 2 Guillain Barre Syndrome Therapeutics: 2.1 Overview 2.2 Etiology and Pathophysiology 2.3 Epidemiology 2.4 Symptoms 2.5 Diagnosis 2.6 Treatment and Management Pattern 2.7 GlobalData Report Guidance 3 Guillain Barre Syndrome Therapeutics: 3.1 GBS Therapeutics Market Size (2005-2010) - Global 3.2 GBS Therapeutics Market Forecast (2010-2017) - Global 3.3 GBS Therapeutics Market Size (2005-2010): The US 3.4 GBS Therapeutics Market Forecast (2010-2017): The US 3.5 GBS Therapeutics Market (2005-2010): France 3.6 GBS Therapeutics Market Forecast (2010-2017): France 3.7 GBS Therapeutics Market (2005-2010): Germany 3.8 GBS Therapeutics Market Forecast (2010-2017): Germany 3.9 GBS Therapeutics Market (2005-2010): Italy 3.10 GBS Therapeutics Market Forecast (2010-2017): Italy 3.11 GBS Therapeutics Market (2005-2010): Spain 3.12 GBS Therapeutics Market Forecast (2010-2017): Spain 3.13 GBS Therapeutics Market (2005-2010): The UK 3.14 GBS Therapeutics Market Forecast (2010-2017): The UK 3.15 GBS Therapeutics Market (2005-2010): Japan 3.16 GBS Therapeutics Market Forecast (2010-2017): Japan 3.17 Drivers and Barriers for the Guillain Barre Syndrome Therapeutics Market 3.17.1 Drivers for the GBS Therapeutics Market 3.17.2 Barriers for the GBS Therapeutics Market 3.18 Opportunity and Unmet Need Analysis 3.19 Key Takeaway 4 Guillain Barre Syndrome Therapeutics: 4.1 Overview 4.1.1 Strategic Competitor Assessment 4.2 Product Profile for the Major Marketed Products in the GBS Therapeutics Market 4.2.1 Kiovig (Gammagard Liquid + rHuPH20) 4.3 Key Takeaway 5 Guillain Barre Syndrome Therapeutics: 5.1 Overview 6 Guillain Barre Syndrome Therapeutics: 6.1 Overview 7 Guillain Barre Syndrome Therapeutics: 7.1 Key Events Impacting on the Future Market 7.2 Guillain Barre Syndrome Therapeutics: 8 Guillain Barre Syndrome Therapeutics: 8.1 Introduction 8.2 Company Profiles 8.2.1 Baxter Biotherapeutics 8.2.2 Grifols Biologicals Inc 8.2.3 CSL Behring Full Table of Contents is available at: -- http://www.fastmr.com/ About GlobalData GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number